Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO₂ laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women

Posted March 22, 2018

Menopause_250x331 Cruz V.L., Steiner M.L., Pompei L.M., Strufaldi R., Fonseca F.L.A., Santiago L.H.S., Wajsfeld T., Fernandes C.E. Menopause. 2017 Jul 31. doi: 10.1097/GME.0000000000000955. Epub ahead of print

ad_mlt

Recent Posts

$Long-term reliability of fractioned CO₂ laser as a treatment for vulvovaginal atrophy (VVA) symptoms$ Long-term reliability of fractioned CO₂ laser as a treatment for vulvovaginal atrophy (VVA) symptoms
Fractional CO₂ laser for genitourinary syndrome of menopause in breast cancer survivors: clinical, immunological, and microbiological aspects.
Early Regenerative Modifications of Human Postmenopausal Atrophic Vaginal Mucosa Following Fractional CO₂ Laser Treatment
Fractional CO₂ laser of the vagina for genitourinary syndrome of menopause: Is the out-of-pocket cost worth the outcome of treatment?